JP2002503674A5 - - Google Patents

Download PDF

Info

Publication number
JP2002503674A5
JP2002503674A5 JP2000531467A JP2000531467A JP2002503674A5 JP 2002503674 A5 JP2002503674 A5 JP 2002503674A5 JP 2000531467 A JP2000531467 A JP 2000531467A JP 2000531467 A JP2000531467 A JP 2000531467A JP 2002503674 A5 JP2002503674 A5 JP 2002503674A5
Authority
JP
Japan
Prior art keywords
chemical
compound according
nrr
ring
nhr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000531467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002503674A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/002891 external-priority patent/WO1999041276A1/en
Publication of JP2002503674A publication Critical patent/JP2002503674A/ja
Publication of JP2002503674A5 publication Critical patent/JP2002503674A5/ja
Pending legal-status Critical Current

Links

JP2000531467A 1998-02-12 1998-02-12 βシート模倣物およびその使用に関する方法 Pending JP2002503674A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/002891 WO1999041276A1 (en) 1998-02-12 1998-02-12 β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF

Publications (2)

Publication Number Publication Date
JP2002503674A JP2002503674A (ja) 2002-02-05
JP2002503674A5 true JP2002503674A5 (enExample) 2005-12-22

Family

ID=22266392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000531467A Pending JP2002503674A (ja) 1998-02-12 1998-02-12 βシート模倣物およびその使用に関する方法

Country Status (9)

Country Link
EP (1) EP1053246B1 (enExample)
JP (1) JP2002503674A (enExample)
KR (1) KR20010040939A (enExample)
AT (1) ATE230414T1 (enExample)
AU (1) AU748887B2 (enExample)
CA (1) CA2319766A1 (enExample)
DE (1) DE69810513T2 (enExample)
ES (1) ES2192764T3 (enExample)
WO (1) WO1999041276A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064678A2 (en) * 2000-02-29 2001-09-07 Bristol-Myers Squibb Pharma Company Inhibitors of hepatitis c virus ns3 protease
US6534651B2 (en) * 2000-04-06 2003-03-18 Inotek Pharmaceuticals Corp. 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
US7122679B2 (en) 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
US20060276497A1 (en) 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
CN1642550A (zh) * 2002-02-14 2005-07-20 美瑞德生物工程公司 β-折叠模拟物和组合物及其有关方法
WO2009158369A1 (en) 2008-06-25 2009-12-30 Schering Corporation Synthesis and use of heterocyclic antibacterial agents
WO2016057413A2 (en) 2014-10-06 2016-04-14 Cortexyme, Inc. Inhibitors of lysine gingipain
CA3004095A1 (en) 2015-11-09 2017-05-18 Cortexyme, Inc. Inhibitors of arginine gingipain
AU2017317988B2 (en) 2016-08-31 2020-12-24 Jiangsu Hengrui Medicine Co., Ltd. Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof
EP4480541A3 (en) 2016-09-16 2025-04-30 Lighthouse Pharmaceuticals, Inc. Ketone inhibitors of lysine gingipain
JP2021529201A (ja) 2018-07-02 2021-10-28 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司Jiangsu Hengrui Medicine Co., Ltd. オキシピリジンアミド誘導体の結晶形およびその調製方法
JP7450024B2 (ja) 2019-09-27 2024-03-14 シェンヅェン サルブリス ファーマシューティカルズ カンパニー リミテッド FXIa阻害剤及びその調製方法と医薬用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220596B1 (hu) * 1992-02-14 2002-03-28 Merrell Dow Pharmaceuticals Inc. 7-Szubsztituált pirido-benzazepin-karbonsav-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
HU223663B1 (hu) * 1992-05-15 2004-11-29 Merrel Dow Pharmaceuticals Inc. Enkefalináz és ACE gátló hatású 9-[(2-acetil-tio-3-fenil)-propanoil-amino]-piridazo[1,2-a][1,2]diazepin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
EP0618223A3 (en) * 1993-03-08 1996-06-12 Sandoz Ltd Peptides, the release of Interleukin 1-Bêta, useful as anti-inflammatory agents.
WO1996019483A1 (en) * 1994-12-22 1996-06-27 Biochem Pharma Inc. Low molecular weight bicyclic thrombin inhibitors
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
AU713530B2 (en) * 1995-03-24 1999-12-02 Molecumetics, Ltd. Beta-sheet mimetics and use thereof as protease inhibitors
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
ES2262184T3 (es) * 1996-08-05 2006-11-16 Myriad Genetics, Inc. Utilizacion de mimeticos de hojas beta como inhibidores de proteasa y de kinasa o como inhibidores de factores de transcripcion.

Similar Documents

Publication Publication Date Title
JP4264137B2 (ja) 抗血栓性有機硝酸塩
JP2002503674A5 (enExample)
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
SU1681728A3 (ru) Способ получени производных N-(бензтиазолил-2)амидов бензойной или тиазол-4-карбоновой кислоты
JP2005511699A5 (enExample)
KR960014126A (ko) 시클로알카노-인돌 및 -아자인돌 유도체
JP2006507265A5 (enExample)
JP2004516314A5 (enExample)
JP2001526269A5 (enExample)
JP2011520815A5 (enExample)
JP2002356472A5 (enExample)
JP2005505618A5 (enExample)
JP2006509842A5 (enExample)
JP2004532346A5 (enExample)
JPH08508720A (ja) ピロールーアミジン化合物およびその薬剤的に受容できる塩、その製造法ならびにこれを含む医薬組成物
JP2007532628A5 (enExample)
KR960029335A (ko) 9-치환된 2-(2-n-알콕시페닐)-푸린-6- 온
JP2004538278A5 (enExample)
TW593330B (en) Orally active A1 adenosine receptor agonists
JP2005501121A5 (enExample)
RU2004102398A (ru) Производные бензо[g]хинолина для лечения глаукомы и близорукости
JP2006500372A5 (enExample)
JP2003521457A5 (enExample)
EA200801331A1 (ru) Новые двойные ингибиторы пептидаз в качестве пролекарств для лечения воспалительных и других заболеваний
ATE29721T1 (de) 5-(4-vinyl- oder 4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo-(1,2-a -pyrrol-1-carbosaeure und deren derivate.